Subscribe to RSS - insulin


Pharmaceuticals and HME: No parity

Thursday, August 25, 2016

Things have been tough for the HME community for the past few years but this summer has taken it to a whole ‘nother level.

In brief: Two senators back bid bill, groups seek vent changes


WASHINGTON – HME stakeholders have added two co-sponsors to a bill in the Senate that would delay a second round of Medicare reimbursement cuts slated for July 1.

Insulin prices increased threefold over 11-year period


YARMOUTH, Maine – The cost of insulin more than tripled—from $231 per year per patient in 2002 to $736 per year per patient in 2013, according to an analysis published in the Journal of the American Medical Association.

I have a drug problem

Monday, January 18, 2016

Now that you’ve fallen for my cheap, attention-grabbing ploy, let me clarify: after another year of white-knuckling it through “HR analyzes health coverage plans season,” a nightmare has come true.

Insulet loses ground in first quarter


BILLERICA, Mass. – Insulet, maker of the OmniPod insulin management system, reported revenues of $61.2 million for the first quarter of 2015, an 11% decrease compared to the same period last year. Net loss was $11.8 million vs. $6.1 million. "With our U.S.

Insulet reports increase in revenues


BILLERICA, Mass. – Insulet reported revenues of $72.6 million for the fourth quarter of 2014, a 6% increase compared to the same period in 2013. It reported a net loss of $5.4 million vs. $2.5 million.

In brief: Health spending ‘on right track,’ Medicare Advantage enrollment to grow


WASHINGTON – Growth in U.S. healthcare spending over the next 10 years will be modest in comparison to historical trends, according to a Sept. 18 report from the CMS Office of the Actuary.

Global insulin market to hit $40.2B by 2018, report says


WELLESLEY, Mass. – The market for insulin and insulin delivery devices, which was $24 billion last year and should reach $25.7 billion this year, will grow significant in the next five years, according to a recent report from BCC Research.

Insulet hits financial milestone


BEDFORD, Mass. – Insulin pump maker Insulet reported revenues of $60.1 million for the second quarter ended June 30, 2013, an 18% increase compared to the same period last year. Gross profit was $26.8 million, compared to $22.3 million.

Prodigy teams up with pharmacy


CHARLOTTE, N.C. – Prodigy Diabetes Care has formed a partnership with Rx ‘n Go, an alternative pharmacy network, to offer fixed price diabetes monitors and test strips, according to a press release.